These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 26799188)
1. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296 [TBL] [Abstract][Full Text] [Related]
3. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer. Zhang Y; Li Y; Han L; Zhang P; Sun S Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis. Hu S; Liu J; Feng S; Wang Y; Liu H Aging (Albany NY); 2021 Apr; 13(9):12479-12492. PubMed ID: 33902004 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339 [TBL] [Abstract][Full Text] [Related]
6. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. Zhang S; Zhong G; He W; Yu H; Huang J; Lin T J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma. Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer. Na-Er A; Xu YY; Liu YH; Gan YJ Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma. Zhou Y; He P; Xie X; Sun C Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911 [TBL] [Abstract][Full Text] [Related]
11. LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis. Zhang LM; Wang P; Liu XM; Zhang YJ Am J Transl Res; 2017; 9(12):5461-5472. PubMed ID: 29312498 [TBL] [Abstract][Full Text] [Related]
12. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related]
13. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a. Liu J; Song Z; Feng C; Lu Y; Zhou Y; Lin Y; Dong C Am J Transl Res; 2017; 9(12):5594-5602. PubMed ID: 29312511 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway. Tian C; Jin Y; Shi S Oncol Lett; 2018 Nov; 16(5):6109-6115. PubMed ID: 30333879 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer. Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088 [TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression. Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R Front Oncol; 2024; 14():1325157. PubMed ID: 38846969 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein. Guo Y; Wang Y; Ma Y; Chen G; Yue P; Li Y RSC Adv; 2020 Feb; 10(10):6006-6016. PubMed ID: 35497433 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]